Streetbeat News

Price Targets

AEP

BE

Bloom Energy's stock surged 59% after announcing a major deal with American Electric Power to supply up to 1 GW of solid oxide fuel cells. Analysts have revised Bloom Energy's stock price targets.

Portfolio Pulse from

November 16, 2024 | 12:45 pm

IPAR

Interparfums reported strong Q3 results and anticipates good Q4 performance. However, the company expects slower growth from 2025, leading to a downgrade in its growth guidance. The current valuation of IPAR does not support this slower growth outlook.

Portfolio Pulse from

November 16, 2024 | 9:30 am

RIVN

A Wall Street analyst has set a price target of $23 for Rivian stock, which is currently trading at around $10.50. This suggests a potential upside for investors considering buying at the current price.

Portfolio Pulse from

November 15, 2024 | 6:15 pm

AMZN

HIMS

Hims & Hers Health, Inc.'s stock has dropped over 25% due to Amazon's entry into the hair loss and ED markets. However, the company's focus on personalized solutions and strong growth provides a competitive edge, suggesting the pessimism is overblown. The stock has a 38% upside potential with a $27.5 price target.

Portfolio Pulse from

November 15, 2024 | 6:00 pm

RYAAY

Wall Street analysts have set an average price target for Ryanair (RYAAY) indicating a potential upside of 26.3%. This is supported by positive trends in earnings estimate revisions, suggesting a possible increase in the stock price.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

GLUE

Wall Street analysts have set a mean price target for Monte Rosa Therapeutics (GLUE) that suggests a potential 100.5% upside. Despite the historical ineffectiveness of price targets, the consensus among analysts in raising earnings estimates indicates a positive outlook for the stock.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

MBI

Wall Street analysts suggest a potential 33.8% upside for MBIA (MBI) based on the consensus price target. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions could indicate a near-term stock price increase.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

CNNE

Analysts have set a price target for Cannae Holdings (CNNE) that suggests a potential 35.4% upside. Despite the mixed reliability of price targets, the consensus among analysts in raising earnings estimates supports a positive outlook for CNNE.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

IAS

Integral Ad Science (IAS) has a consensus price target indicating a potential 39.3% upside. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions suggest a possible near-term stock price increase.

Portfolio Pulse from

November 15, 2024 | 4:15 pm

ADPT

Wall Street analysts predict a 31.36% upside for Adaptive Biotechnologies (ADPT) based on consensus price targets. Despite skepticism about the effectiveness of price targets, upward earnings estimate revisions suggest potential near-term gains for ADPT.

Portfolio Pulse from

November 15, 2024 | 4:15 pm